JD Health (06618) launches evidence-based medicine AI product "Zhiyi" to assist doctors in clinical and research scenarios.
"Zh y" will be fully integrated into the JD Doctor app, and open to all doctors for experience.
On January 17, 2026, the annual JD Health Doctor Awards Ceremony was held in Beijing. At the event, JD Health unveiled the evidence-based medical AI product "Zhiyi" specially designed for doctors.
According to reports, this product focuses on two core scenarios: clinical decision-making and scientific research, deeply integrating millions of authoritative medical data worldwide. It can quickly screen, highly integrate massive authoritative literature and guidelines, and directly output actionable conclusions, improving the quality and efficiency of clinical diagnosis and treatment for doctors, and providing strong support for research exploration.
It is reported that "Zhiyi" will be fully integrated into the JD Doctor APP, open for experience for all doctors, whether or not they are part of the JD Internet Hospital, can use this evidence-based medical AI product.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


